Body's own cell-to-cell messaging packets studied as the basis for next-generation medicines
Researchers are investigating extracellular vesicles (EVs), which are cell-to-cell messaging packets, as a potential foundation for next-generation regenerative medicines. The study aims to develop methods for the large-scale manufacturing of these nanoparticles to treat conditions like cancer and inflammation.
Why it matters
Advancements in EV technology could revolutionize regenerative medicine and provide new therapeutic pathways for currently difficult-to-treat diseases.
by Germans Trias i Pujol Research Institute
The report is a technical summary of scientific research published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in